BamSEC and AlphaSense Join Forces
Learn More

Cadrenal Therapeutics Inc. – Material Contracts

NASDAQ: CVKD    
Share price (6/26/26): $3.05    
Market cap (6/26/26): $9.389 million
Search in Documents
Key Exhibits
External Links

Material Contracts Filter

EX-10.1
from 8-K 8 pages Confidential Separation Agreement and General Release
12/34/56
EX-10.1
from 8-K 9 pages Holder of Common Stock Purchase Warrants Re: Inducement Offer to Exercise Common Stock Purchase Warrants Dear Holder
12/34/56
EX-10.1
from 8-K 43 pages Securities Purchase Agreement
12/34/56
EX-10.3
from 8-K 5 pages First Amendment to Amended and Restated Exclusive License Agreement
12/34/56
EX-10.2
from 8-K 21 pages Amended and Restated Exclusive License Agreement
12/34/56
EX-10.1
from 8-K 41 pages Asset Purchase Agreement
12/34/56
EX-10.1
from 8-K 26 pages Asset Purchase Agreement
12/34/56
EX-10.1
from 8-K 16 pages Collaboration Agreement
12/34/56
EX-10.2
from 8-K 8 pages Private and Confidential
12/34/56
EX-10.1
from 8-K 18 pages Employment Agreement
12/34/56
EX-10.1
from 8-K 10 pages Holder of Common Stock Purchase Warrants Re: Inducement Offer to Exercise Common Stock Purchase Warrants Dear Holder
12/34/56
EX-10.1
from 8-K 2 pages Amendment to the Cadrenal Therapeutics, Inc. 2022 Successor Equity Incentive Plan Dated: July 29, 2024
12/34/56
EX-10.2
from 8-K 23 pages Employment Agreement
12/34/56
EX-10.1
from 8-K 2 pages February 6, 2024 Cash Compensation ● Upon the Start Date, the Executive Is Deemed to Be a W-2 Employee of Cadrenal Therapeutics, Inc. ● Annual Base Salary at $405,000; Paid Bi-Monthly in Accordance With Normal Company Policy ● Annual Targeted Cash Bonus – 40% of Base Equity Compensation ● 150,000 Options (Granted on January 18, 2024; Exercise Price of $0.94) ● 150,000 Additional Options Which Shall Be Granted No Later Than March 14, 2024 ● Vesting: 25% at 1-Year Anniversary, Balance Monthly Over 36 Months ● Executive Is Eligible for Annual Equity Grants Commensurate With Other Members of the Executive Leadership Team and/or Market Data (As Determined by the Compensation Committee of the Board of Directors) Standard Employee Benefits ● Participation in 401k Plan; Matching Contribution
12/34/56
EX-10.3
from 8-K 4 pages Lock-Up Agreement
12/34/56
EX-10.2
from 8-K 28 pages Registration Rights Agreement
12/34/56
EX-10.1
from 8-K 41 pages Securities Purchase Agreement
12/34/56
EX-10.1
from 8-K 2 pages Amendment No. 1 to Employment Agreement
12/34/56
EX-10.4
from 8-K 21 pages Employment Agreement
12/34/56
EX-10.3
from 8-K 22 pages Employment Agreement
12/34/56